company background image
002653 logo

Haisco Pharmaceutical Group XSEC:002653 Stock Report

Last Price

CN¥31.89

Market Cap

CN¥35.4b

7D

1.1%

1Y

58.3%

Updated

01 Feb, 2025

Data

Company Financials +

Haisco Pharmaceutical Group Co., Ltd.

XSEC:002653 Stock Report

Market Cap: CN¥35.4b

002653 Stock Overview

Research, develops, manufactures, and sells pharmaceuticals in China. More details

002653 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance3/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 42.7% below our estimate of its fair value

Earnings are forecast to grow 35.67% per year

Earnings grew by 27.1% over the past year

Risk Analysis

Large one-off items impacting financial results

Dividend of 0.91% is not well covered by free cash flows


My Notes

Capture your thoughts, links and company narrative

Haisco Pharmaceutical Group Co., Ltd. Competitors

Humanwell Healthcare (Group)Ltd

SHSE:600079

CN¥35.0b

Changchun High-Tech Industry (Group)

SZSE:000661

CN¥37.7b

Dong-E-E-JiaoLtd

SZSE:000423

CN¥39.0b

Shenzhen Salubris Pharmaceuticals

SZSE:002294

CN¥33.3b

Price History & Performance

Summary of share price highs, lows and changes for Haisco Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥31.89
52 Week HighCN¥40.66
52 Week LowCN¥18.59
Beta0.078
1 Month Change-1.88%
3 Month Change-12.65%
1 Year Change58.34%
3 Year Change84.12%
5 Year Change44.63%
Change since IPO85.51%

Recent News & Updates

Recent updates

Shareholder Returns

002653CN PharmaceuticalsCN Market
7D1.1%0.2%-0.9%
1Y58.3%12.8%22.0%

Return vs Industry: 002653 exceeded the CN Pharmaceuticals industry which returned 12.8% over the past year.

Return vs Market: 002653 exceeded the CN Market which returned 22% over the past year.

Price Volatility

Is 002653's price volatile compared to industry and market?
002653 volatility
002653 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 002653 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002653's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20055,448Xiu Lian Fanwww.haisco.com

Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals in China. The company offers cycloporol, dolasetron mesylate, polyene phosphatidylcholine, compound amino acid, and methylprednisolone sodium injections, as well as flupenthixol melitracen tablets. It offers its products in various therapeutic fields, including anesthesia, parenteral nutrition, tumor antiemetic, liver, gallbladder digestion, antibiotics, cardiovascular, and cerebrovascular.

Haisco Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Haisco Pharmaceutical Group's earnings and revenue compare to its market cap?
002653 fundamental statistics
Market capCN¥35.37b
Earnings (TTM)CN¥476.19m
Revenue (TTM)CN¥3.72b

74.3x

P/E Ratio

9.5x

P/S Ratio

Is 002653 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002653 income statement (TTM)
RevenueCN¥3.72b
Cost of RevenueCN¥1.04b
Gross ProfitCN¥2.69b
Other ExpensesCN¥2.21b
EarningsCN¥476.19m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 12, 2025

Earnings per share (EPS)0.43
Gross Margin72.17%
Net Profit Margin12.79%
Debt/Equity Ratio49.4%

How did 002653 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

80%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 00:53
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Haisco Pharmaceutical Group Co., Ltd. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Shanshan LiChina Merchants Securities Co. Ltd.
Sophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)